Wyeth Effexor XR

Journal advertisements for venlafaxine using the tag lines "beyond better to well" and "bring patients to true wellness" draw objections from FDA in an Oct. 11 letter to the company. The antidepressant's claims imply "that it will be unlikely that condition will return," the letter states. FDA instructs Wyeth to cease similar advertisements for the extended release capsules. Wyeth is preparing a response to the letter